CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 371 enrolled
Drug / intervention
DSXS topical +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02933866
NCT02933866Phase 3Completed
CompareCT.gov

A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III Clinical Study to Evaluate the Efficacy and Safety of DSXS Topical Product in Patients With Mild to Severe Scalp Psoriasis

Sun Pharmaceutical Industries, Inc.·interventional·Posted Oct 14, 2016·Updated Dec 6, 2018

In Brief

A Phase 3 clinical trial evaluating DSXS topical and Vehicle topical for Scalp Psoriasis. Completed, enrolled 371 participants across 1 site.

Detailed Summary

A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III Clinical Study to Evaluate the Efficacy and Safety of DSXS topical product in Patients with Mild to Severe Scalp Psoriasis

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScalp Psoriasis
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 14, 2016
Enrollment StartMar 11, 2016
Primary CompletionNov 16, 2016
Study CompletionSep 29, 2017
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.7 years ago

Interventions

DSXS topicaldrug

topical treatment

Vehicle topicaldrug

topical treatment